Comparative study of angiogenesis in thyroid glands with graves disease and Hashimoto's thyroiditis

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 2, 2006, Pages 203-207

  Tseleni Balafouta, Sofia ^a,b   Kavantzas, Nikos ^a   Balafoutas, Dimitrios ^a   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Angiogenesis; Thyroid autoimmunity

Indexed keywords

ANGIOGENESIS; ARTICLE; AUTOIMMUNE DISEASE; CANCER; CONTROLLED STUDY; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THYROID GLAND; THYROIDITIS;

ADULT; AGED; ANTIGENS, CD31; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; THYROID GLAND;

EID: 33745431463     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000174262.33385.5e     Document Type: Article

References (21)

1. Volpé R. Suppressor T lymphocyte dysfunction is important in the pathogenesis of autoimmune thyroid disease: a perspective. Thyroid. 1993;3:345-349.
2. Fisfalen ME, Palmer EM, Van Sevanter GA. Thyrotropin receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab. 1997;82:3655-3666.
3. Strivatsa B, Strivatsa S, Johnson KL, et al. Microchimerism of presumed fetal origin in thyroid specimens for women: a case control study. Lancet. 2001;358:2034-2038.
4. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
5. Ramsden JD. Angiogenesis in the thyroid gland. J Endocrinol. 2000;166:475-480.
6. Castagnone D, Rivolta R, Rescalli S, et al. Color doppler sonography in Graves disease: value in assessing activity of disease and predicting outcome. AJR Am J Roentgenol. 1996;166:203-207.
7. Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
8. Viglietto G, Romano A, Manzo G, et al. Upregulation of the angiogenic factors PIGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization. Oncogene. 1997;15:2687-2698.
9. Itaka M, Miura S, Yamanaka K, et al. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves disease and Hashimoto's thyroiditis. J Clin Endocrinol Melab. 1998;83:3908-3912.
10. Wang JF, Milosveski V, Schramek C, et al. Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function. J Endocrinol. 1998;157:5-12.
11. Kavantzas N, Tseleni-Balafouta S, Davaris P. Computerized nuclear morphometry and quantitation of angiogenesis in thyroid neoplasms. J Exp Clin Cancer Res. 2002;21:247-254.
12. Poulaki V, Mitsiades CS, McMullan C, et al. Regulation of vascular endothelial growth factor expression I insulin-like growth factor I in thyroid carcinomas. J Clin Endocrinol Metab. 2003;88:5392-5398.
13. Thompson SD, Franklyn JA, Watkinson JC, et al. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid. J Clin Endocrinol Metab. 1998;83:1336-1341.
14. Maiorano E, Perlino E, Triggiani V, et al. Insulin-like growth factor-1 and insulin-like growth factor receptor in thyroid tissues of patients with Graves disease. Int J Mol Med. 1998;2:483-486.
15. Wang H, Keiser J. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: the role of flt-1. Circ Res. 1998;83:832-840.
16. Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity. 2003;36:351-359.
17. Wollman SH, Herveg JP, Zeligs JD, et al. Blood capillary enlargement during the development of thyroid hyperplasia in the rat. Endocrinology. 1978;103:2306-2314.
18. Goodman AL, Rone JD. Thyroid angiogenesis: endotheliotropic chemoattachant activity from rat thyroid cells in culture. Endocrinology. 1987;121:2131-2140.
19. Connons JM, Huffman LJ, Hedge GA. Effects of thyrotropin on vascular conductance of the thyroid gland. Endocrinology. 1988;122:921-929.
20. Lopez-Lopez C, LeRoith D, Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA. 2004;29:9833-9834.
21. Zhang D, Bar-Eli M, Meloche S, et al. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/ARt and Raf/ERk pathways transmit opposing signals. J Biol Chem. 2004;279:19683-19690.